new
formula
reduc
ethanol
content
combin
phosphor
acid
exhibit
broad
spectrum
virucid
activ
quantit
suspens
test
without
protein
load
formul
reduc
infect
titr
seven
envelop
influenza
b
herp
simplex
bovin
corona
respiratori
syncyti
vaccinia
hepat
b
bovin
viral
diarrhoea
four
nonenvelop
hepat
polio
rota
felin
calici
virus
fold
within
compar
test
ethanol
show
similar
level
activ
fingerpad
test
formul
produc
log
reduct
factor
titr
polioviru
type
sabin
compar
test
felin
caliciviru
produc
log
reduct
factor
test
formul
contrast
log
reduct
factor
ethanol
respect
mani
pathogen
virus
remain
viabl
human
hand
hour
give
hand
potenti
spread
infecti
agent
directli
indirectli
set
hospit
recent
studi
experiment
contamin
fingertip
substanti
potenti
hand
spread
virus
observ
reemphas
need
proper
hand
disinfect
prevent
control
nosocomi
outbreak
viral
infect
particular
howev
hand
disinfect
often
test
veget
bacteria
may
reflect
abil
deal
virus
alcoholbas
hand
rub
gener
broader
rel
rapid
antimicrobi
activ
often
limit
abil
inactiv
nonenvelop
virus
rais
ethanol
content
may
address
issu
degre
increas
risk
tissu
toxic
lower
flash
point
present
one
formul
broad
virucid
activ
exist
ethanol
content
vol
therefor
effort
made
reduc
ethanol
content
without
reduc
virucid
activ
decreas
flash
point
increas
skin
toler
complianc
result
effort
synergist
combin
develop
ethanol
content
ww
combin
ww
ww
ww
phosphor
acid
readytous
formul
regist
us
food
drug
administr
sinc
introduct
evalu
product
austrian
hospit
relev
unwant
sideeffect
report
date
follow
cell
use
fl
amnion
cell
stephan
angeloff
institut
microbiolog
sofia
bulgaria
atcc
dulbecco
modifi
eagl
medium
dmem
gibco
brl
paisley
scotland
uk
contain
heatinactiv
fetal
bovin
serum
gibco
brl
grand
island
ny
usa
supplement
mmoll
hepe
buffer
vwr
intern
gmbh
darmstadt
germani
antibiot
penicillin
uml
streptomycin
mgml
cercopithecu
monkey
kidney
cell
polioviru
type
stock
viru
suspens
infecti
titr
ccid
ml
centrifug
low
speed
g
beckman
instrument
portervil
plant
ca
usa
min
sediment
resuspend
dulbecco
phosphatebuff
salin
pb
centrifug
low
speed
clarifi
supernat
contain
titr
least
ccid
ml
fingerpad
experi
sabin
vaccin
strain
polioviru
type
lsc
atcc
kindli
provid
behringwerk
ag
liederbach
germani
abovement
strain
fcv
use
three
male
four
femal
adult
particip
fingerpad
test
use
polioviru
type
fcv
strain
volunt
receiv
oral
polio
vaccin
seroposit
neutral
test
confirm
write
inform
consent
particip
studi
ethic
committe
central
hospit
bremen
germani
gave
permiss
clinic
studi
test
hand
volunt
care
inspect
preclud
dermatos
open
wound
skin
disord
assess
influenc
ethanol
content
efficaci
polioviru
type
three
commerci
hand
disinfect
test
dilut
undilut
form
product
contain
ww
ethanol
activ
ingredi
product
b
contain
ww
ethanol
combin
nonion
deterg
product
c
contain
ww
ethanol
combin
benzalkonium
chlorid
clorophen
develop
new
formul
hereaft
call
test
product
variou
differ
chemic
tabl
screen
combin
ethanol
concentr
ww
chemic
purchas
vwr
intern
gmbh
final
formul
readytous
prepar
contain
ww
ethanol
ww
ww
ww
phosphor
acid
test
undilut
solut
use
quantit
suspens
assay
formul
regular
concentr
activ
ingredi
produc
result
concentr
test
product
test
vacciniavirusand
fcvinactiv
properti
formul
use
result
test
product
vitro
experi
formul
test
dilut
doubledistil
water
fingerpad
test
polioviru
test
product
refer
standard
vv
use
recommend
en
test
fcv
vv
ethanol
vv
includ
refer
guidelin
german
feder
health
offic
robert
kochinstitut
berlin
germani
dvv
test
effect
chemic
disinfect
virus
strictli
follow
briefli
viru
suspens
serum
albumin
sigmaaldrich
st
loui
mo
usa
fc
doubledistil
water
hand
disinfect
hand
disinfect
dilut
brought
one
part
viru
suspens
mix
either
one
part
doubledistil
water
one
part
serum
albumin
solut
one
part
fc
protein
load
ad
experi
rotaviru
sinc
fc
rotavirusinhibitori
trypsinneutr
activ
eight
part
formul
ad
prepar
mixtur
kept
water
bath
exposur
period
end
exposur
period
serial
dilut
control
test
sampl
prepar
immedi
icecold
cultur
medium
ml
sampl
ml
medium
inocul
respect
host
cell
suspens
place
microtitr
plate
costar
cambridg
usa
incub
six
eight
well
per
sampl
dilut
inocul
viru
control
prepar
contain
ident
protein
concentr
cytopath
effect
record
microscop
infecti
viru
titr
ccid
evalu
endpoint
dilut
method
reed
muench
log
reduct
factor
hereaft
call
reduct
factor
rf
determin
subtract
logarithm
titr
ccid
test
point
logarithm
titr
ccid
viru
control
confid
limit
reduct
factor
obtain
accord
emea
guidelin
quantit
suspens
test
disinfect
solut
consid
virucid
efficaci
within
test
exposur
period
titr
reduc
least
fold
inactiv
mean
rf
regard
suffici
practic
purpos
howev
gener
virucid
efficaci
follow
titr
rang
fold
due
cytotox
substanc
test
fingerpad
method
efficaci
hand
disinfect
consid
comparison
select
refer
indirect
immunofluoresc
test
use
detect
hav
contact
sampl
dilut
inocul
cell
incub
plate
three
week
cell
sheet
scrape
rubber
policeman
transfer
standard
microscop
slide
smear
dri
fix
cold
aceton
min
treat
min
humid
atmospher
antihav
human
hyperimmun
serum
titr
abbott
enzymelink
immunosorb
assay
antihav
immunoglobulin
g
indirect
immunofluoresc
test
vs
hav
hm
f
strain
cell
twice
rins
min
pb
min
distil
water
sampl
dri
treat
min
place
humid
atmospher
dilut
antihuman
fluorescein
isothiocyan
label
goat
serum
nation
centr
infecti
parasit
diseas
supplement
contrast
solut
evan
blue
vwr
intern
gmbh
final
solut
sampl
rins
twice
pb
min
wash
distil
water
dri
observ
fluoresc
microscop
viru
titr
calcul
accord
reed
muench
addit
control
cytotox
includ
parallel
virucid
test
eight
part
hand
disinfect
mix
two
part
dulbecco
pb
serial
dilut
prepar
ad
respect
host
cell
suspens
effect
compound
test
cellular
morpholog
trace
overt
sign
cytotox
end
period
infecti
viru
assay
record
report
data
mean
valu
three
repeat
experi
carri
simultan
ccid
evalu
accord
routin
reed
muench
method
dlog
rf
valu
compar
untreat
control
consid
statist
signific
minimum
effect
concentr
dlog
rf
valu
consid
borderlin
depend
test
condit
threshold
demonstr
virucid
efficaci
hbv
reduct
fold
studi
perform
polioviru
type
accord
astm
standard
fcv
accord
astm
standard
briefli
ml
viru
suspens
place
demarc
area
fingerpad
inoculum
allow
dri
dri
inoculum
expos
ml
refer
vv
ethanol
vv
vv
standard
hard
water
shw
test
formul
contain
glass
vial
serolab
aidenbach
germani
contact
time
either
polioviru
test
test
without
soil
load
perform
wherea
fcv
tripartit
soil
load
accord
bovin
serum
albumin
mucin
trypton
includ
viru
remain
fingerpad
elut
ml
earl
balanc
salt
solut
contain
trypton
fcv
without
trypton
afterward
viru
titr
eluat
determin
directli
endpoint
titrat
polioviru
titrat
gmkah
cell
fcv
titrat
ker
cell
microtitr
plate
calcul
viru
titr
fingerpad
method
perform
method
spearman
three
control
includ
determin
amount
infecti
viru
inoculum
infecti
viru
place
two
thumbpad
without
dri
infecti
viru
remain
fingerpad
dri
inoculum
differ
infecti
viru
inoculum
control
dri
viru
control
repres
loss
viru
infect
due
dri
inoculum
amount
infecti
viru
remain
dri
inoculum
use
baselin
determin
extent
viru
elimin
treatment
test
product
refer
use
four
randomli
select
fingerpad
treatment
test
product
two
treatment
refer
ethanol
concentr
alon
product
well
combin
deterg
product
b
phenol
quaternari
ammonium
compound
product
c
suffici
effect
rf
polioviru
within
min
tabl
ii
therefor
combin
longerchain
alcohol
test
select
basic
formul
ethanol
ww
phosphor
acid
effect
combin
tabl
due
replac
aceton
lower
efficaci
measur
addit
miner
acid
import
efficaci
wherea
differ
influenc
phosphor
acid
hcl
tabl
iii
previou
test
formul
lactic
acid
stabl
three
month
data
shown
content
ww
essenti
get
defin
vivo
efficaci
surgic
disinfect
data
shown
expect
influenza
virus
b
hsv
type
rsv
vaccinia
viru
hrv
bvdv
surrog
hepat
c
viru
prove
quit
sensit
action
formul
test
virus
inactiv
within
even
presenc
protein
load
tabl
iv
replic
bcv
surrog
sever
acut
respiratori
syndrom
corona
viru
sarscov
could
determin
test
product
even
abl
inactiv
fcv
surrog
noroviru
contact
time
even
presenc
protein
load
hav
inactiv
test
product
use
concentr
within
polioviru
inactiv
min
hbv
also
inactiv
within
sv
clearli
resist
min
need
inactiv
viru
presenc
protein
load
min
without
protein
adenoviru
strain
type
resist
test
viru
result
efficaci
hand
disinfect
without
protein
load
within
min
protein
addit
within
min
test
product
significantli
effect
polioviru
fingerpad
test
vv
rf
tabl
v
comparison
valu
refer
solut
respect
signific
level
exposur
time
result
fcv
shown
tabl
vi
present
studi
virucid
activ
formul
polioviru
evalu
develop
comparison
three
alcoholbas
hand
disinfect
furthermor
broad
spectrum
human
pathogen
virus
caus
nosocomi
infect
surrog
includ
later
studi
design
quantit
suspens
test
without
protein
load
test
envelop
virus
inactiv
exposur
time
result
rf
test
product
also
abl
inactiv
resist
nonenvelop
virus
ethanol
ww
combin
longchain
alcohol
reach
high
virucid
efficaci
polioviru
exposur
time
min
anoth
studi
ethanol
abl
inactiv
echoviru
compar
tenac
echoviru
polioviru
belong
enterovirus
lower
concentr
ethanol
fail
inactiv
echoviru
exposur
time
min
addit
anoth
product
high
ethanol
content
combin
peracet
acid
display
poliovirusinactiv
properti
remark
effect
test
product
demonstr
test
hav
hav
inactiv
found
exposur
time
anoth
studi
alcohol
mixtur
high
content
ethanol
ethanol
isopropanol
abl
reduc
viru
titr
rf
min
furthermor
two
product
high
concentr
ethanol
effect
hav
without
addit
protein
rf
disinfect
disinfect
exposur
time
min
past
fingerpad
test
method
accord
shown
produc
result
compar
wholehand
model
test
commerci
avail
product
base
upon
ethanol
mm
mm
polioviru
type
strain
sabin
similar
rf
found
test
system
fingerpad
test
wholehand
model
therefor
comparison
demonstr
fingerpad
method
valuabl
establish
recommend
use
hand
disinfect
fingerpad
test
polioviru
exposur
time
min
low
percentag
ethanol
formul
vv
combin
longchain
alcohol
consider
effect
refer
vv
vv
ethanol
fcv
surrog
noroviru
viru
reduct
measur
show
test
product
effect
ethanol
rf
test
product
tripartit
soil
load
interestingli
alcohol
concentr
vv
describ
previous
highest
virucid
activ
fcv
test
practic
condit
comparison
concentr
contrast
test
two
commerci
avail
product
base
ethanol
ethanol
faecal
suspens
organ
load
product
higher
alcohol
concentr
significantli
effect
formul
lower
content
rf
respect
data
deriv
quantit
suspens
assay
fingerpad
test
demonstr
well
advantag
test
product
fill
clinic
relev
gap
virucid
hand
disinfect
demonstr
effici
safe
fastact
inactiv
mani
human
pathogen
virus
surrog
caus
nosocomi
infect
